Pulmonx Corporation (LUNG) News
Follow Pulmonx Corporation (LUNG) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Pulmonx announces inducement equity grants under Nasdaq Rule 5635(c)(4)
Pulmonx (LUNG) said it granted equity awards on September 1, 2026 under its 2025 inducement grants program tied to Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 01, 2026, 08:07 PM UTC
L
Pulmonx announces inducement grants under Nasdaq Rule 5635(c)(4)
Pulmonx Corporation announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 01, 2026, 08:05 PM UTC
L
Pulmonx to participate in upcoming investor conferences
Pulmonx says it will participate in upcoming investor conferences.
EQUITY | Aug 27, 2026, 08:07 PM UTC
L
LUNG - Pulmonx to Participate in Upcoming Investor Conferences
LUNG - Pulmonx to Participate in Upcoming Investor Conferences
EQUITY | Aug 27, 2026, 08:05 PM UTC
H
PRCH +20%, CORT +18.3%, BOOM +17.3%, FORM +16.4%, SBUX +10.2%, FTNT +9.4%, BHE +9.3%, LUNG +8.8%, LRCX +7.6%, CMG +7.1%, GKOS +7%, GFL +5.7%
PRCH +20%, CORT +18.3%, BOOM +17.3%, FORM +16.4%, SBUX +10.2%, FTNT +9.4%, BHE +9.3%, LUNG +8.8%, LRCX +7.6%, CMG +7.1%, GKOS +7%, GFL +5.7%, RGR 4.8%, MOD +3.9%, ICLR +3.8%, ST +3.6%, MAX +2.6%, EQIX +2.4% after results
EARNINGS | Jul 29, 2026, 08:27 PM UTC
L
Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.832M Est
Pulmonx (NASDAQ: LUNG ) affirms FY2026 sales outlook from $90.000 million-$92.000 million to $90.000 million-$92.000 million vs $90.832 million estimate.
EARNINGS | Jul 29, 2026, 08:15 PM UTC
L
LUNG Pulmonx RESULTS: Q2, Q2 REV $22.756M vs. EST $22.4M, Q2 gross profit $17.742M, Q2 Net Income $-10.08M, Q2 Income from operations $-9.05
LUNG Pulmonx RESULTS: Q2, Q2 REV $22.756M vs. EST $22.4M, Q2 gross profit $17.742M, Q2 Net Income $-10.08M, Q2 Income from operations $-9.057M, Q2 pretax profit $-9.947M, Q2 EPS $-0.24, Pulmonx Earnings Notes:, Outlook F
EARNINGS | Jul 29, 2026, 08:10 PM UTC
L
LUNG - Pulmonx Reports Second Quarter 2026 Financial Results
LUNG - Pulmonx Reports Second Quarter 2026 Financial Results
EARNINGS | Jul 29, 2026, 08:07 PM UTC
H
serial disappointer risk (missed last qtr) in EPS reporters tonight and tomorrow morning - HOOD, VTR, MKL, HLI, MGM, ARMN, NFG, MC, AM, QTWO
serial disappointer risk (missed last qtr) in EPS reporters tonight and tomorrow morning - HOOD, VTR, MKL, HLI, MGM, ARMN, NFG, MC, AM, QTWO, CVI, TDOC, ALKT, MGRC, BBNX, PMT, MAX, LXU, CLB, MDXG, CLMB, FPI, UAN, MFIN, L
EARNINGS | Jul 29, 2026, 05:04 PM UTC